An mRNA-LNP Vaccine Platform Tailoring the Immunogenicity Profile from Prophylactic to Therapeutic Applications, Reducing Reactogenicity and Extending Shelf-Life Stability
Time: 12:30 pm
day: Conference Day Two
Details:
- Addressing shortcomings in the immunogenicity, reactogenicity and stability of current mRNA vaccines by optimizing the lipid nanoparticle components
- Investigating the addition of targeting lipids to tune the immunogenicity profile towards the requirements of different prophylactic and therapeutic applications
- Extending the shelf-life of mRNA vaccines by developing lyophilizable LNPs and microneedle-array patches
